machinery for production expansion of Packaging amounting to THB 35 mil. Net cash provided from financing received of THB 941 mil. due mainly to cash receipts from long-term loan of THB 333 mil. and increase
10% from those of 31 December 2017. The major increase item is raw material which is aimed to promptly support the expected higher production volume in second quarter. Investments in associated
1,834 million or 24% from those of 31 December 2017. The major increase item is raw material which is aimed to promptly support the expected higher production volume in fourth quarter. Investments in
materials used in production was lower than the year 2018. 5 . Cost from the water management business for quarter 3/ 2019 was 65.84% of income. The cost per income rate decreased compared to quarter 3/2018
increased by Baht 2.60 million. 5. Administrative expense increased baht 21.86 million mainly resulting from Amortize costs of production Baht 23.76 million. The main products distributed by the company
investors, which can lead to business expansion, employment, and more competitive edge of local businesses. This translates into the overall economic benefits of the country at large thanks to a close
the sales of products. Therefore, the Corporate Group has established policy on market expansion and domestic channel development to achieve the most efficiency, as well as production cost management
product quality (the company has been awarded ISO 13485, the Quality Management System for Medical Device Industry), which is an important tool in the competition and expansion of the market in the future
to No.90, CW Tower B, 21st Floor, Ratchadapisek Road, Huaykwang, Bangkok. On 5 June 2017, the Company started recognizing revenue from the design, construct and operate a potable water production
% compared to the same period last year as sales in China stagnated since the end of last year. Nevertheless, the Company’s business expansion to the Philippines helps extend the customer base and diversify